Condition:   Urinary Tract Infections
Interventions:   Drug: Trimethoprim sulfamethoxazole, amoxicillin-clavulanate, cefixime, or cephalexin;   Drug: Placebo
Sponsors:   Children's Hospital of Philadelphia;   Children's Hospital of Philadelphia;   Children's Hospital of Pittsburgh;   University of Pennsylvania;   Westat;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012

Condition:   Cystic Fibrosis
Interventions:   Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
Sponsors:   Johns Hopkins University;   Michael Boyle;   Case Western Reserve University;   Cystic Fibrosis Foundation
Not yet recruiting - verified May 2012

Conditions:   cUTI;   Complicated Urinary Tract Infection;   Acute Pyelonephritis
Interventions:   Drug: CAZ-AVI;   Drug: Doripenem
Sponsors:   AstraZeneca;   AstraZeneca;   Cerexa, Inc.
Not yet recruiting - verified May 2012

Condition:   Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions:   Drug: CAZ-AVI;   Drug: Doripenem;   Drug: Either 500 mg of Ciprofloxacin (oral);   Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors:   AstraZeneca;   AstraZeneca;   Cerexa, Inc.
Not yet recruiting - verified May 2012

Conditions:   Skin and Soft Tissue Abscess;   Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention:   Drug: Oral Clindamycin
Sponsors:   Children's Memorial Hospital;   Children's Memorial Hospital
Recruiting - verified December 2011

Conditions:   Cystic Fibrosis;   Methicillin-resistant Staphylococcus Aureus
Interventions:   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole;   Drug: Minocycline;   Drug: Mupirocin;   Drug: chlorhexidine gluconate oral rinse;   Drug: 2% Chlorhexidine solution wipes;   Behavioral: Environmental Decontamination
Sponsors:   University of North Carolina, Chapel Hill;   University of North Carolina, Chapel Hill;   CF Therapeutics Development Network Coordinating Center;   Seattle Children's Hospital;   University of Washington;   University of Colorado, Denver;   Texas Children's Hospital;   University of Alabama at Birmingham;   St. Louis Children's Hospital;   Cook Children's Medical Center;   University of Michigan Health System
Recruiting - verified January 2012

Conditions:   Obesity;   Pharmacokinetics;   MRSA;   Tuberculosis;   PCP
Intervention:   Drug: Sulfamethoxazole/trimethoprim
Sponsors:   Texas Tech University Health Sciences Center;   Texas Tech University Health Sciences Center;   National Center for Research Resources (NCRR);   University of Texas Southwestern Medical Center
Recruiting - verified February 2012

Condition:   Catheter-Associated Urinary Tract Infection
Interventions:   Drug: Bactrim;   Other: Placebo
Sponsors:   The Cleveland Clinic;   The Cleveland Clinic;   American Urogynecologic Society
Recruiting - verified February 2012

Condition:   Abscess
Interventions:   Drug: Trimethoprim-sulfamethoxazole;   Drug: Sugar pill
Sponsors:   Children's Mercy Hospital Kansas City;   Children's Mercy Hospital Kansas City;   Blue Cross Blue Shield
Recruiting - verified June 2011

Condition:   Methicillin-Resistant S.Aureus
Interventions:   Drug: Clindamycin;   Drug: Placebo;   Drug: Trimethoprim-sulfamethoxazole (TS)
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011

Condition:   Methicillin-Resistant S.Aureus
Interventions:   Drug: Cephalexin;   Drug: Placebo;   Drug: Trimethoprim-sulfamethoxazole (TS);   Drug: Clindamycin
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012

Conditions:   Vesico-Ureteral Reflux;   Urinary Tract Infections
Interventions:   Drug: Trimethoprim-Sulfamethoxazole;   Drug: Placebo
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012